Holen Sie sich die Stockscreener-App
82.34
0.13%
0.11
Handel nachbörslich:
81.19
-1.15
-1.40%
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt AZN?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$82.23
Offen:
$82.09
24-Stunden-Volumen:
5.83M
Relative Volume:
1.22
Marktkapitalisierung:
$255.37B
Einnahmen:
$56.53B
Nettoeinkommen (Verlust:
$8.32B
KGV:
30.93
EPS:
2.6622
Netto-Cashflow:
$8.49B
1W Leistung:
-1.27%
1M Leistung:
+7.33%
6M Leistung:
+14.70%
1J Leistung:
+13.06%
1-Tages-Spanne:
$81.29
$82.82
1-Wochen-Bereich:
$81.29
$84.22
52-Wochen-Spanne:
$61.24
$86.57
Astrazeneca PLC Stock (AZN) Company Profile
Firmenname
Astrazeneca PLC
Sektor
Branche
Telefon
44 20 3749 5000
Adresse
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge
Vergleichen Sie AZN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AZN
Astrazeneca PLC
|
82.34 | 254.96B | 56.53B | 8.32B | 8.49B | 2.6622 |
Astrazeneca PLC Stock (AZN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-27 | Fortgesetzt | Jefferies | Buy |
| 2025-10-16 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-04-15 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2025-02-13 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-12 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-20 | Hochstufung | UBS | Sell → Neutral |
| 2024-11-06 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2024-09-13 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-04-16 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2024-02-08 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2024-01-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-01-16 | Fortgesetzt | UBS | Sell |
| 2024-01-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-25 | Hochstufung | Jefferies | Hold → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-12 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-05 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-04-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-01-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-09-15 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-29 | Hochstufung | Argus | Hold → Buy |
| 2022-06-14 | Herabstufung | UBS | Buy → Neutral |
| 2022-02-11 | Hochstufung | DZ Bank | Sell → Hold |
| 2021-12-07 | Herabstufung | Jefferies | Buy → Hold |
| 2021-08-12 | Fortgesetzt | JP Morgan | Overweight |
| 2021-04-12 | Herabstufung | Argus | Buy → Hold |
| 2021-03-16 | Hochstufung | Jefferies | Hold → Buy |
| 2021-02-25 | Hochstufung | UBS | Neutral → Buy |
| 2021-01-15 | Eingeleitet | Deutsche Bank | Buy |
| 2020-12-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-30 | Hochstufung | UBS | Sell → Neutral |
| 2020-11-11 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2020-09-29 | Eingeleitet | Berenberg | Buy |
| 2019-11-22 | Eingeleitet | SVB Leerink | Outperform |
| 2019-10-25 | Hochstufung | Liberum | Hold → Buy |
| 2019-04-02 | Herabstufung | UBS | Neutral → Sell |
| 2019-02-05 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2019-01-25 | Hochstufung | Shore Capital | Hold → Buy |
| 2018-12-11 | Fortgesetzt | Jefferies | Hold |
| 2018-10-09 | Eingeleitet | Guggenheim | Buy |
| 2018-08-16 | Herabstufung | Jefferies | Buy → Hold |
| 2018-03-19 | Hochstufung | Jefferies | Hold → Buy |
| 2018-02-06 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-05 | Bestätigt | Bernstein | Outperform |
| 2018-01-18 | Bestätigt | Leerink Partners | Mkt Perform |
| 2017-12-29 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-10-16 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2017-09-25 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2017-09-22 | Hochstufung | Bernstein | Mkt Perform → Outperform |
Alle ansehen
Astrazeneca PLC Aktie (AZN) Neueste Nachrichten
Up 47%, Should You Buy IonQ Right Now? - The Motley Fool
Technical signs of recovery in AstraZeneca PLC Depositary ReceiptJuly 2025 Update & Consistent Profit Alerts - newser.com
Why AstraZeneca PLC (ZEG) stock stays on buy listsTrade Performance Summary & Precise Swing Trade Alerts - newser.com
How AstraZeneca PLC (ZEG) stock trades under stagflationMarket Weekly Review & Accurate Technical Buy Alerts - newser.com
FDA Streamlines Biosimilar Development; Impacts AstraZeneca (AZN) - GuruFocus
Jennison Associates LLC Has $850.26 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat
Institutional scanner results for AstraZeneca PLC Depositary ReceiptJuly 2025 Action & Daily Volume Surge Signals - newser.com
Using Python tools to backtest AstraZeneca PLC Depositary Receipt strategies2025 AllTime Highs & Detailed Earnings Play Strategies - newser.com
Is AstraZeneca PLC (Common Stock) (ZEGA) stock a top pick for value investorsMarket Trend Summary & Smart Allocation Stock Tips - newser.com
Will Precidian ETFs Trust AstraZeneca PLC stock hit Wall Street targetsJuly 2025 Breakouts & Free Verified High Yield Trade Plans - newser.com
Will AstraZeneca PLC (ZEG) stock profit from AI boomDividend Hike & Risk Controlled Daily Trade Plans - newser.com
Has AstraZeneca PLC Depositary Receipt formed a bullish divergenceWeekly Stock Report & Safe Capital Growth Trade Ideas - newser.com
AstraZeneca PLC Stock Flat Wednesday, Outperforms Market - 富途牛牛
Astrazeneca Canada Health Canada granted notice of compliance for Enhertu - MarketScreener
James Investment Research Inc. Sells 5,088 Shares of AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC Depositary Receipt stock chart pattern explainedDay Trade & Fast Momentum Entry Tips - newser.com
AstraZeneca PLC $AZN Shares Sold by Bessemer Group Inc. - MarketBeat
Why ETFs are accumulating AstraZeneca PLC (ZEG) stockJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
Using fundamentals and technicals on AstraZeneca PLC Depositary ReceiptChart Signals & High Accuracy Swing Trade Signals - newser.com
Astrazeneca (AZN) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
AstraZeneca non-executive director Euan Ashley joins DexCom board - Investing.com
AstraZeneca non-executive director Euan Ashley joins DexCom board By Investing.com - Investing.com UK
AstraZeneca news: momentum mixed as RSI nears oversold, but price holds session highs - Traders Union
AstraZeneca PLC $AZN Stock Position Decreased by Envestnet Asset Management Inc. - MarketBeat
AstraZeneca receives EU approval for Koselugo in adult neurofibromatosis - Investing.com
How AstraZeneca PLC Depositary Receipt stock responds to policy changes2025 Volume Leaders & Daily Risk Controlled Trade Plans - newser.com
AstraZeneca receives EU approval for Koselugo in adult neurofibromatosis By Investing.com - Investing.com UK
AstraZeneca's Koselugo Receives EU Approval for Rare Disease Tre - GuruFocus
United States Adult Vaccine Market Research and Company Analysis Report 2025-2033 Featuring GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer, and CSL Limited - Yahoo Finance
Oppenheimer Asset Management Inc. Grows Position in AstraZeneca PLC $AZN - MarketBeat
What market sentiment indicators show for Precidian ETFs Trust AstraZeneca PLC stockEarnings Summary Report & Long-Term Growth Plans - newser.com
Cobblestone Capital Advisors LLC NY Trims Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca’s Koselugo approved in EU for adult neurofibromatosis - Investing.com
AstraZeneca’s Koselugo approved in EU for adult neurofibromatosis By Investing.com - Investing.com Nigeria
What makes AstraZeneca PLC (ZEG) stock appealing to growth investorsEarnings Growth Report & Community Supported Trade Ideas - Fundação Cultural do Pará
AstraZeneca's Koselugo receives EU approval - Sharecast.com
AstraZeneca's Koselugo (Selumetinib) approved in EU - MarketScreener
REGAstraZeneca PLCDirector Declaration - TradingView
Is AstraZeneca PLC Depositary Receipt meeting your algorithmic filter criteriaPortfolio Update Report & Proven Capital Preservation Methods - newser.com
Will AstraZeneca PLC (ZEG) stock test record highs in 20252025 Earnings Surprises & Proven Capital Preservation Methods - newser.com
Published on: 2025-10-27 23:22:45 - newser.com
How AstraZeneca PLC (Common Stock) (ZEGA) stock performs during market turbulenceJuly 2025 Macro Moves & Reliable Price Breakout Signals - newser.com
Can AstraZeneca PLC Depositary Receipt stock sustain revenue growthQuarterly Portfolio Summary & Free Real-Time Volume Trigger Notifications - newser.com
Risk vs reward if holding onto AstraZeneca PLC Depositary ReceiptBreakout Watch & Safe Capital Investment Plans - newser.com
Can AstraZeneca PLC Depositary Receipt stock hit analyst price targetsJuly 2025 News Drivers & Community Consensus Stock Picks - Fundação Cultural do Pará
AstraZeneca PLC (NASDAQ:AZN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Finanzdaten der Astrazeneca PLC-Aktie (AZN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):